Tag Archives: Intermed

Australia: Docetaxel case

[Bloomberg] The interlocutory petition for restraining generic launch of Docetaxel in Australia is denied by federal judge. Docetaxel product per se is protected by patent no AU591309 (expiry: Feb 06, 2011) and composition is protected by patent no AU666859 (expiry: July 2012). … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment